NCT00378638View on ClinicalTrials.gov

Dose-Dense Chemotherapy Plus Bevacizumab in High Risk Lymph Node Positive Breast Cancer: A Pilot Study

PHASE2UnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 2006

Study Completion Date

October 31, 2008

Conditions
Breast Cancer
Interventions
DRUG

bevacizumab combined with dose dense chemotherapy

Trial Locations (1)

90404

RECRUITING

Premiere Oncology, Santa Monica

Sponsors

Collaborators (1)

Genentech, Inc.
All Listed Sponsors
collaborator

Genentech, Inc.

INDUSTRY

lead

Chap, Linnea I., M.D.

INDIV